News

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the online marketplace stocks, including The RealReal (NASDAQ:REAL) and its peers.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the professional tools and equipment industry, including Fortive (NYSE:FTV) and its peers.

What a brutal six months it’s been for 10x Genomics. The stock has dropped 52.1% and now trades at $10.59, rattling many shareholders. This was partly due to its softer quarterly results and might have investors contemplating their next move.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at therapeutics stocks, starting with Myriad Genetics (NASDAQ:MYGN).

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Flowserve (NYSE:FLS) and the rest of the gas and liquid handling stocks fared in Q4.

(Bloomberg) -- Thailand will provide tax incentives for investments in the nation’s equity market that has underperformed peers this year amid foreign outflows. Most Read from BloombergNJ College to Merge With State School After Financial StressNYC Congestion Pricing Toll Gains Support Among City ResidentsBuffalo’s Billion-Dollar Freeway Fix Is on Ice, But Not Because of TrumpWhere New York City's Zoning Reform Will Add HousingInside the ‘Not Architecture’ of High Line Designers Diller Scofidio

Target is facing tough times as consumers cut back on spending. It's also at the center of culture war controversies over DEI and Pride.